MICCAI 2021 Daily - Tuesday

Low-dose-rate prostate brachytherapy is an effective curative treatment for men with prostate cancer. Physicians implant small radioactive seeds inside the prostate, which is a far less radical approach than a prostatectomy, where physicians remove the entire prostate gland. However, side effects from the radiotherapy can have a detrimental effect on a patient’s quality of life afterwards. This can occur if the rectum, which is very close to the prostate, or the urethra, which passes through the prostate, are radiated during the treatment. Unless the cancer is at a critical stage, doctors will often advise waiting and monitoring the situation instead. Tajwar Abrar Aleef is a fourth-year biomedical engineering PhD candidate in the Robotics and Control Laboratory at the University of British Columbia, working under the supervision of Septimiu Salcudean and Sara Mahdavi. He is presenting for the first time at MICCAI this year and has the honor of being a first author on not one, but two accepted papers! He speaks to us ahead of his oral presentation and poster session today, which explores a novel approach to prostate cancer treatment planning. Rapid treatment planning for low-dose-rate prostate brachytherapy with TP-GAN 4 DAILY MICCAI Tuesday Oral Presentation